1. Home
  2. HAS vs ABVX Comparison

HAS vs ABVX Comparison

Compare HAS & ABVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hasbro Inc.

HAS

Hasbro Inc.

HOLD

Current Price

$95.15

Market Cap

11.1B

ML Signal

HOLD

Logo Abivax SA American

ABVX

Abivax SA American

HOLD

Current Price

$109.34

Market Cap

9.2B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
HAS
ABVX
Founded
1923
2013
Country
United States
France
Employees
N/A
N/A
Industry
Recreational Games/Products/Toys
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
11.1B
9.2B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
HAS
ABVX
Price
$95.15
$109.34
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
10
11
Target Price
$93.80
$130.09
AVG Volume (30 Days)
1.8M
1.6M
Earning Date
02-10-2026
03-23-2026
Dividend Yield
2.90%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$4,357,000,000.00
$6,231,374.00
Revenue This Year
$10.19
$6.80
Revenue Next Year
$5.44
N/A
P/E Ratio
N/A
N/A
Revenue Growth
0.79
N/A
52 Week Low
$49.00
$4.77
52 Week High
$97.41
$148.83

Technical Indicators

Market Signals
Indicator
HAS
ABVX
Relative Strength Index (RSI) 70.35 39.52
Support Level $87.90 $107.42
Resistance Level $97.41 $116.72
Average True Range (ATR) 1.92 5.18
MACD 0.60 -0.92
Stochastic Oscillator 81.73 13.99

Price Performance

Historical Comparison
HAS
ABVX

About HAS Hasbro Inc.

Hasbro is a branded play company providing children and families around the world with entertainment offerings based on a world-class brand portfolio. From toys and games to television programming, motion pictures, and a licensing program, Hasbro reaches customers by leveraging its well-known brands such as Transformers, Nerf, and Magic: The Gathering. The firm acquired EOne in 2019, bolting on popular family properties like Peppa Pig and PJ Masks, and since has divested noncore lines from the tie-up. Furthermore, the addition of Dungeons & Dragons Beyond in 2022, offers the firm access to 19 million digital tabletop players.

About ABVX Abivax SA American

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD.

Share on Social Networks: